US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Definium Therapeutics

34.90

+0.72002.11%

Volume:66.24K

Turnover:2.31M

Market Cap:4.69B

PE:-10.02

High:35.01

Open:34.85

Low:34.69

Close:34.18

52wk High:49.70

52wk Low:10.46

Shares:134.37M

Float Shares:129.97M

Volume Ratio:1.50

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.4823

EPS(LYR):-2.0600

ROE:-64.09%

ROA:-20.64%

PB:5.10

PE(LYR):-16.94

Loading ...

Overview Company News Filings

FDA to Hold Public Hearing on Psychedelic Drugs as Trump-Driven Push Gathers Pace

Analysts’ Top Healthcare Picks: Corbus Pharmaceuticals (CRBP), Definium Therapeutics (DFTX)

Top Midday Stories: No OpenAI IPO in 2026, Altman Reportedly Says; Nvidia, Palantir Said to Restrict AI Usage Over Customer Data Fears

MT Newswires Live

First Marijuana, Then Peptides. Why Psychedelics are Wall Street's Next Big Trip.

Definium Therapeutics Inc : Leerink Partners Raises Target Price to $70 from $52

THOMSON REUTERS

Definium Therapeutics Price Target Maintained with a $66.00/Share by Needham

Definium Therapeutics Shares Gain After Reporting Positive Results in Anxiety Study

Definium Therapeutics Shares Jump 20% Premarket After Co's Lsd-Based Drug Lowers Anxiety in Second Successful Late-Stage Study

THOMSON REUTERS

S&P 500 Futures Decline in Premarket Trading; Definium Therapeutics, Primo Brands Lead

Definium Therapeutics: DT120 Odt 100 Mcg Generally Well Tolerated with Consistent Safety Profile; no New Safety Signals

THOMSON REUTERS

Definium Therapeutics: DT120 Pre-Nda Meeting Scheduled for Q4; Nda Filing Expected H1 2027

THOMSON REUTERS

Definium Therapeutics: Phase 3 Panorama Study of DT120 Odt Met Primary & Key Secondary Endpoints in Generalized Anxiety Disorder

THOMSON REUTERS

Definium's LSD-Based Drug Lowers Anxiety in Second Successful Late-Stage Study

Definium Therapeutics: DT120 Odt 100 Mcg Showed Placebo-Adjusted Hamilton Anxiety Rating Scale Reduction of 5.1 Points at Week 12

THOMSON REUTERS

NASDAQ Trade Halt Halt News Pending at 06:55 Am

U.S. Research Roundup-ACV Auctions, Crown Castle, Lennox International

Definium Therapeutics Issues Inducement Stock Options for 56,650 Shares to New Hires

Definium Therapeutics to Present Phase 3 Panorama Topline Data for DT120 in Generalized Anxiety Disorder Sept. 14

Definium Therapeutics to Discuss Topline Results from Phase 3 Panorama Study in Generalized Anxiety Disorder on September 14, 2026

THOMSON REUTERS

Definium Therapeutics' Upcoming Phase 3 Data on DT120 to De-Risk Program, Back FDA Approval, RBC Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/DFTX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DFTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":34.9,"timestamp":1791553065617,"preClose":34.18,"halted":0,"volume":66236,"delay":0,"changeRate":0.021064950263311844,"floatShares":129971489,"shares":134366950,"eps":-3.482311,"marketStatus":"Trading","change":0.72,"latestTime":"10-09 09:37:49 EDT","open":34.85,"high":35.005,"low":34.69,"amount":2309642.6964000002,"amplitude":0.009216,"askPrice":34.94,"askSize":457,"bidPrice":34.67,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-3.482311,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":34.18,"preHourTrading":{"tag":"盘前","latestPrice":34.86,"preClose":34.18,"latestTime":"09:29 EDT","volume":8156,"amount":289205.96924,"timestamp":1791552599999,"change":0.68,"changeRate":0.019895,"amplitude":0.061147},"postHourTrading":{"tag":"盘后","latestPrice":34.4969,"preClose":34.18,"latestTime":"19:57 EDT","volume":36874,"amount":1260530.4461,"timestamp":1791503879344,"change":0.3169,"changeRate":0.009272,"amplitude":0.009272},"volumeRatio":1.501321,"impliedVol":0.5919,"impliedVolPercentile":0.0109},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","floatShares":129971489,"roa":"-20.64%","roe":"-64.09%","lyrEps":-2.059999,"volumeRatio":1.501321,"shares":134366950,"dividePrice":0,"high":35.005,"amplitude":0.009216,"preClose":34.18,"low":34.69,"week52Low":10.4646,"pbRate":"5.10","week52High":49.7,"institutionHeld":0,"latestPrice":34.9,"committee":0.044932,"eps":-3.482311,"divideRate":0,"volume":66236,"delay":0,"ttmEps":-3.482311,"open":34.85,"prevYearClose":13.39,"prevWeekClose":37.4,"prevMonthClose":38.06,"prevQuarterClose":38.06,"fiveDayClose":37.4,"twentyDayClose":38.89,"sixtyDayClose":44.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DFTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"DFTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-1.44},{"market":"US","date":"2026-05-07","symbol":"DFTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.47,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2026-02-26","symbol":"DFTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DFTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DFTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.6111,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6111,"analysts":18,"updateTime":1787025600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DFTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DFTX","date":"2026-10-08","current":-9.815321,"percent":0.417582,"low":-27.074722,"twenty":-17.041551,"median":-11.678904,"eighty":-9.948453,"high":-8.802064,"avg":-13.976636,"sd":5.118646,"marketCap":4714936275},"quantilePoints":[{"date":"2026-01-16","current":-9.013032,"twenty":-8.970838,"median":-8.907548,"eighty":-8.844258,"marketCap":1515072711},{"date":"2026-01-23","current":-9.944809,"twenty":-9.944809,"median":-9.423248,"eighty":-8.819645,"marketCap":1671702464},{"date":"2026-01-30","current":-10.103035,"twenty":-10.103035,"median":-9.868626,"eighty":-9.013032,"marketCap":1698299969},{"date":"2026-02-06","current":-9.522872,"twenty":-10.196799,"median":-9.918438,"eighty":-9.522872,"marketCap":1600775783},{"date":"2026-02-13","current":-9.511152,"twenty":-10.179218,"median":-9.944809,"eighty":-9.522872,"marketCap":1598805598},{"date":"2026-02-20","current":-10.120616,"twenty":-10.18039,"median":-9.944809,"eighty":-9.520528,"marketCap":1701255248},{"date":"2026-02-27","current":-9.267085,"twenty":-10.187422,"median":-9.96239,"eighty":-9.520528,"marketCap":1703225433},{"date":"2026-03-06","current":-9.519961,"twenty":-10.18039,"median":-9.903787,"eighty":-9.502065,"marketCap":1749702163},{"date":"2026-03-13","current":-9.753213,"twenty":-10.18039,"median":-9.918437,"eighty":-9.518199,"marketCap":1792572359},{"date":"2026-03-20","current":-10.122078,"twenty":-10.169841,"median":-9.903787,"eighty":-9.52229,"marketCap":1860367087},{"date":"2026-03-27","current":-10.273963,"twenty":-10.169841,"median":-9.918437,"eighty":-9.559599,"marketCap":1888282563},{"date":"2026-04-02","current":-11.174427,"twenty":-10.181562,"median":-9.918437,"eighty":-9.550417,"marketCap":2053781457},{"date":"2026-04-10","current":-11.619234,"twenty":-10.247114,"median":-9.944809,"eighty":-9.57529,"marketCap":2135533923},{"date":"2026-04-17","current":-12.18338,"twenty":-10.396104,"median":-9.980506,"eighty":-9.589394,"marketCap":2239219977},{"date":"2026-04-24","current":-12.617338,"twenty":-11.167918,"median":-10.038572,"eighty":-9.618687,"marketCap":2318978480},{"date":"2026-05-01","current":-11.86876,"twenty":-11.389236,"median":-10.10442,"eighty":-9.643639,"marketCap":2181395062},{"date":"2026-05-08","current":-13.767387,"twenty":-11.71579,"median":-10.122078,"eighty":-9.665202,"marketCap":2530349365},{"date":"2026-05-15","current":-9.802755,"twenty":-11.643102,"median":-10.113211,"eighty":-9.689477,"marketCap":2328575817},{"date":"2026-05-22","current":-10.399644,"twenty":-11.570414,"median":-10.105791,"eighty":-9.636028,"marketCap":2470362634},{"date":"2026-05-29","current":-10.780735,"twenty":-11.483622,"median":-10.120616,"eighty":-9.642537,"marketCap":2560888064},{"date":"2026-06-05","current":-11.290386,"twenty":-11.393576,"median":-10.145827,"eighty":-9.660184,"marketCap":2681952193},{"date":"2026-06-12","current":-11.069996,"twenty":-11.344489,"median":-10.179218,"eighty":-9.68473,"marketCap":2629600138},{"date":"2026-06-18","current":-11.216923,"twenty":-11.349156,"median":-10.196799,"eighty":-9.702279,"marketCap":2664501508},{"date":"2026-06-26","current":-20.565124,"twenty":-11.510745,"median":-10.247973,"eighty":-9.723056,"marketCap":4885101210},{"date":"2026-07-02","current":-24.252692,"twenty":-11.77112,"median":-10.299843,"eighty":-9.753213,"marketCap":5761057223},{"date":"2026-07-10","current":-27.074722,"twenty":-12.069466,"median":-10.333633,"eighty":-9.796609,"marketCap":6431410656},{"date":"2026-07-17","current":-24.643864,"twenty":-12.519698,"median":-10.492938,"eighty":-9.802755,"marketCap":5853977501},{"date":"2026-07-24","current":-23.990048,"twenty":-12.931958,"median":-10.537388,"eighty":-9.812883,"marketCap":5698667894},{"date":"2026-07-31","current":-24.861803,"twenty":-14.440728,"median":-10.67054,"eighty":-9.817222,"marketCap":5905747370},{"date":"2026-08-07","current":-17.312135,"twenty":-19.588062,"median":-10.789918,"eighty":-9.824231,"marketCap":6124773739},{"date":"2026-08-14","current":-16.673146,"twenty":-17.887875,"median":-10.831241,"eighty":-9.831914,"marketCap":5898709105},{"date":"2026-08-21","current":-17.242844,"twenty":-17.526933,"median":-11.058518,"eighty":-9.861594,"marketCap":6100259530},{"date":"2026-08-28","current":-16.642763,"twenty":-17.426666,"median":-11.092954,"eighty":-9.887379,"marketCap":5887959749},{"date":"2026-09-04","current":-14.432336,"twenty":-17.33018,"median":-11.139168,"eighty":-9.901443,"marketCap":5105944100},{"date":"2026-09-11","current":-14.329791,"twenty":-17.27056,"median":-11.195675,"eighty":-9.903787,"marketCap":5069665023},{"date":"2026-09-18","current":-14.690599,"twenty":-17.210941,"median":-11.23988,"eighty":-9.921368,"marketCap":5197313626},{"date":"2026-09-25","current":-13.949992,"twenty":-17.164605,"median":-11.372203,"eighty":-9.935823,"marketCap":4935298073},{"date":"2026-10-02","current":-14.280417,"twenty":-17.093203,"median":-11.537867,"eighty":-9.941944,"marketCap":5052197320},{"date":"2026-10-08","current":-13.327123,"twenty":-17.041551,"median":-11.678904,"eighty":-9.948453,"marketCap":4714936275}],"updateTime":1791552558256},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DFTX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667667454","title":"FDA to Hold Public Hearing on Psychedelic Drugs as Trump-Driven Push Gathers Pace","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667454","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667454?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:20","pubTimestamp":1789402802,"startTime":"0","endTime":"0","summary":"FDA to hold public hearing on psychedelic drugs as Trump-driven push gathers paceSept 14 (Reuters)-The U.S. Food and Drug Administration will hold a public hearing on Monday to gather feedback on the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4N4531CQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","GHRS","ATAI","BK4007","PSIL","CMPS","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667409","title":"Analysts’ Top Healthcare Picks: Corbus Pharmaceuticals (CRBP), Definium Therapeutics (DFTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667409","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667409?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:10","pubTimestamp":1789402226,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Corbus Pharmaceuticals (CRBP) and Definium Therapeut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-corbus-pharmaceuticals-crbp-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-corbus-pharmaceuticals-crbp-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LU0029874061.USD","BK4588","LABU","BK4139","XLV","CRBP","BK4585","DFTX","BK4581","HCSG","BK4007","BK4137","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667678916","title":"Top Midday Stories: No OpenAI IPO in 2026, Altman Reportedly Says; Nvidia, Palantir Said to Restrict AI Usage Over Customer Data Fears","url":"https://stock-news.laohu8.com/highlight/detail?id=2667678916","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667678916?lang=en_us&edition=fundamental","pubTime":"2026-09-14 23:56","pubTimestamp":1789401389,"startTime":"0","endTime":"0","summary":"All three major US stock indexes were down in late-morning trading Monday, as major artificial intelligence companies flagged concerns about the risks posed to humanity by the rapid advancement of AI ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4608","LU0345769128.USD","IE0001KFT4U8.USD","LU2023250330.USD","LU2125909247.SGD","LU2471134523.USD","LU2505996509.AUD","PRVT","LU0109391861.USD","BK4605","LU2065171402.SGD","LU2552382215.SGD","LU0289941410.SGD","NVII","IE00BJTD4N35.SGD","LU2023251221.USD","LU0342679015.USD","09388","LU1691799644.USD","LU2100268510.USD","LU2168563687.JPY","LU2552382058.USD","MSFW","LU1037948897.HKD","NVD","LU2275660780.HKD","PLTI","BK4527","LU1121112475.USD","LU2764262908.HKD","LU0738911758.USD","LU0719512351.SGD","IE00B775H168.HKD","LU1868836914.USD","IE00BQXX3D17.EUR","LU0175139822.USD","NVD3.UK","BAH","LU2077746001.SGD","LU1668664300.SGD","SOXY","BK4548","LU0211327993.USD","MSFO","LU0553294199.USD","LU0708994859.HKD","LU2097344431.USD","LU0061474960.USD","LU2896262040.SGD","LU2089283258.USD","BK4581","LU1699723380.USD","LU1989772923.USD","SG9999014559.SGD","SG9999018865.SGD","LU1032955483.USD","LU0345770993.USD","SNPE","LU1880398471.USD","PTIR","XLK","LU1992135472.HKD","LU2506952097.USD","NVDB","LU2092937221.SGD","LU0096362180.USD","LU1144417596.USD","LU2756315318.SGD","MSFL","PSP","LU1228905540.USD","SG9999001424.SGD","LU2168564149.EUR","LU0894485498.HKD","LU0395794307.EUR","SG9999018857.SGD","SPTE","IE00BHPRN162.USD","BK4614","SHLD","LU0314104364.USD","IE00BSNM7G36.USD","LU1400636491.USD","LU2097344357.USD","IE0004091025.USD","LU1035775433.USD","LU1935043023.USD","LU2491049909.HKD","BK4598","CMAG","LU3102509885.SGD","LU2213496289.HKD","LU0289739343.SGD","KBWP","IE00BYQQ9H92.USD","LU1804176565.USD","IE00B775SV38.USD","IE00BN29S564.USD","LU1244550494.USD","AIFD","LU1815336760.USD","LU1992135399.USD","SGXZ51526630.SGD","LU1221951046.USD","IE00BBT3K403.USD","LU2403377893.USD","BK4535","LU0256863902.USD","CHPX","LU0320765059.SGD","SNVD.UK","LU1116320737.USD","IE00BKPKM429.USD","IETC","LU1923623000.USD","LU0390134368.USD","IE00B1XK9C88.USD","NVDS.UK","NVC","LU1814569148.SGD","IE00BGHQF748.EUR","LU0444971666.USD","IE00BZ9MQY76.HKD","BK4566","LU1935042991.SGD","LU2244417387.USD","HK0000819398.USD","LU2360106780.USD","LU1712237335.SGD","EYES","LU2746668974.SGD","LU2473716301.USD","HK0000914660.USD","LU0157215616.USD","LU0786609619.USD","LU0950375773.USD","LU2463028550.USD","FDTX","IE00BFXG1179.USD","LU0788109477.HKD","BK4588","ORAC","LU2125909916.SGD","LU1642822529.SGD","LU2471134796.USD","ESLG","LU0048573561.USD","LFGY","IE00BKVL7J92.USD","NVDD","SG9999014542.SGD","LU1244550221.USD","SG9999014914.USD","LU2041044095.USD","LU2999663052.SGD","METV","LU0107464264.USD","LU0154236417.USD","IE00BFXG0V08.USD","BK4516","LU0225283273.USD","LU0323591593.USD","LU0683600562.USD","LU2322448957.HKD","LU0823417653.USD","LU0965509010.AUD","BK4023","LU0889565833.HKD","IE00BQXX3F31.USD","LU2242650005.HKD","IE00B5949003.HKD","IE00B4YYXB79.USD","BK4007","LU1720051017.SGD","LU2750360997.AUD","LU0056508442.USD","LU1323610961.USD","LU2168564065.EUR","ORCZ","LU2265009873.SGD","SMHX","LU2931357623.SGD","NVDU","LU2191332357.HKD","LU0266013472.USD","EFIV","LU0949170772.SGD","LU1923622614.USD","BK4525","LU1228905037.USD","LU2089284900.SGD","LU2210149790.SGD","LU0302445910.USD","LU1935043536.SGD","IE00B19Z3B42.SGD","LU0070217475.USD","LU2357125470.USD","SG9999014906.USD","THMR","LU1803068623.USD","LU2250418816.HKD","GB00B4QBRK32.GBP","LU2168564222.USD","LU0312595415.SGD","LU1988902786.USD","SG9999011175.SGD","LU2294711713.HKD","LU0784383803.USD","LU2462157665.USD","LU0133085943.USD","LU1003077747.HKD","IE000Q6AESB8.SGD","PLTL","BK4097","LU2860962120.EUR","KKR","LU0095938881.EUR","LU1868837136.USD","LU2362541273.HKD","LU1585245621.USD","IE00BDCRKT87.USD","LU1670628061.USD","IE00B5TLWC47.USD","LU0879622024.SGD","AIPI","IE00BFSS8Q28.SGD","IE0009356076.USD","LU0096364046.USD","LU0251142724.SGD","IE00B1BXHZ80.USD","LU1803068979.SGD","LU0347712357.USD","HK0000532082.HKD","LU2047632596.USD","LU0859254822.USD","HK0000914686.HKD","LU1823568750.SGD","LU1206712785.SGD","SHOC","PLTY","LU0345770308.USD","SGXZ80539844.SGD","BK4585","LU2362541513.USD","IE000MB6IJN5.SGD","LU0820561909.HKD","LU0354030511.USD","LU0345768153.USD","LU0784385170.HKD","LU2506951875.HKD","LU2286300806.USD","MSFY","LU1267930730.SGD","LU1670710588.SGD","LU0494093205.USD","LU1430594728.SGD","PLTZ","SG9999002224.SGD","LU0640476718.USD","LU0642271901.SGD","IE0002270589.USD","LU0757359368.USD","LU0353189763.USD","LU2458330169.SGD","LU0267386448.USD","LU1670711123.USD","LU2506952170.USD","LU0320765489.SGD","LU1435385759.SGD","LU1064131342.USD","IE0009G5SDU7.USD","LU1564329032.USD","LU1633808545.USD","IE00B7KXQ091.USD","LU0672654240.SGD","LU0082616367.USD","IE00B3QW5Z07.USD","LU0690374961.EUR","LU1718418525.SGD","LU0210533765.USD","LU1267930573.SGD","SORCLmain","LU1153585028.USD","LU0124676726.USD","LU2264538146.SGD","LU0345768740.USD","LU2347655156.SGD","BK4576","IE00BLSP4452.SGD","LU0211328371.USD","IE00B4JS1V06.HKD","LU2148611432.USD","BK4141","BK4612","LU2954938101.SGD","LU1564329628.SGD","LU1206713676.USD","LU0314106906.USD","LU2237443549.SGD","LU2471134879.HKD","JGRO","LU1232071149.USD","PLT","IE00BN8TJ469.HKD","NVDG","LU0942090050.USD","LU2491050154.USD","IE0005OL40V9.USD","LU2552382132.HKD","SG9999014575.USD","LU1697837992.HKD","GB00BDT5M118.USD","LU0215105999.USD","WISE","IE00B19Z9Z06.USD","LU1551013342.USD","TTXU","LU0061475181.USD","LU0648001328.SGD","LU0251132253.USD","LU1861558580.USD","BK4550","LU1935043452.HKD","LU2236285917.USD","LU0068578508.USD","BK4173","LU1935042488.USD","VT","LU0964807845.USD","LU0689626769.HKD","LU1934455277.USD","NVDW","LU0784384876.USD","LU0985489474.SGD","SG9999000418.SGD","LU1084165304.USD","IE0004445015.USD","LU0061474705.USD","LU0077335932.USD","LU2237443465.HKD","SGXZ23171101.USD","BWIN","LU0094547139.USD","NVDS","IE00BQXX3C00.GBP","LU0757359954.USD","LU0128525929.USD","LU0979878070.USD","LU0345774631.USD","LU2462591277.SGD","PLOO","LU0011850046.USD","LU0143551892.USD","LU2347655073.USD","IE00B894F039.SGD","LU0820561818.USD","LU1496350171.SGD","LU0417517546.SGD","LU2506951792.HKD","SG9999015978.USD","LU2028103732.USD","IE000M9KFDE8.USD","IE000W1ABFV2.USD","HK0000306701.USD","LU1116320901.HKD","LU1069347547.HKD","ROM","CNEQ","LU0353189680.USD","GB00B4LPDJ14.GBP","LU0138981039.USD","PLTD","IE00BJLML261.HKD","LU2452424414.USD","LU2111349929.HKD","LU1429558221.USD","IE0034235295.USD","IE00B3S45H60.SGD","LU0708995401.HKD","LU2272731600.USD","IE0004445239.USD","DFTX","LU2237957811.SGD","MSFT","BK4554","LU2102340556.USD","NVDX","LU2404859741.USD","BK4579","BK4587","LU1951200564.SGD","LU1861220033.SGD","NVDA","LU1267930813.SGD","LU1242518931.SGD","LU1732799900.SGD","LU2272731865.HKD","NVD2.UK","IE000ITXATA3.USD","LU0861579265.USD","BK4504","LU0234572021.USD","LU0476273544.USD","LU0187121727.USD","BK4551","LU1059921491.USD","LU0943347566.SGD","IE000SO60NU8.SGD","LU1582987324.SGD","IGV","IE00BK4W5L77.USD","LU0742534661.SGD","LU0795875086.SGD","NVDL","LU1839511570.USD","LU1951198990.SGD","LU0171293334.USD","BK4559","LU2271345857.HKD","BK4567","BK4529","LU0557290698.USD","LU1340139317.AUD","LU1989764748.USD","LU1989773731.SGD","IE0004086264.USD","LU0308772762.SGD","LU2210150020.SGD","LU2430703095.HKD","BK4135","LU0238689110.USD","SMH","LU0456855351.SGD","LU1868836757.USD","IE00BK4W5M84.HKD","SG9999015945.SGD","07388","LU0894486033.HKD","IE00BLSP4239.USD","IE00B3M56506.USD","SG9999015986.USD","PLYY","LU2381873111.SGD","LU0006306889.USD","LU1674673428.USD","LU2247934214.USD","LU1506573853.SGD","SNVDAmain","IE00B3SWFQ91.USD","LU2413666699.HKD","LU2065171311.SGD","GUNZ","LU2290526834.HKD","MSFU","HK0000320264.USD","LU1674673691.USD","LU0276348264.USD","LU1181866309.USD","LU0265550946.USD","PLTU","LU0072462426.USD","LU2065170008.USD","LU1989763005.USD","LU0080751232.USD","LU0348723411.USD","LU1043141123.HKD","LU1623119135.USD","LU1196500208.SGD","LU2237443978.SGD","LU2462591350.SGD","LU1202635105.USD","LU0444973449.USD","LU1791710400.SGD","IE0034235188.USD","LU1267930490.SGD","LU0823434583.USD","LU2543165471.USD","NULC","LU0823421416.USD","LU2125909593.SGD","LU2065169927.USD","LU2361044949.HKD","SG9999002232.USD","LU2106854487.HKD","LU0878866978.SGD","AAUM","LU0689472784.USD","LU2764263039.SGD","ILDR","LU2360107168.USD","NVYY","LU2054465674.USD","SG9999017495.SGD","SG9999003800.SGD","SGXZ31699556.SGD","LU0545039389.USD","SG9999014567.USD","09788","LU0210528500.USD","LU0310799852.SGD","SMSFTmain","LU2430703251.USD","MSFD","LU2168564495.EUR","TEK","LU0426412945.USD","LU1645745479.HKD","LU1235294995.USD","IE00B64PRP62.GBP","LU0472753341.HKD","IE00B19Z8X17.USD","LU1400636657.SGD","LU2326559502.SGD","LU0053666078.USD","LU0965508806.USD","LU1496350502.SGD","LU1582986359.USD","ANV","LU2506951958.HKD","LU2746668461.USD","LU2361045086.USD","LU2764263203.CNY","LU0029864427.USD","LU0323240290.USD","LU0203202063.USD","LU0726765562.USD","SG9999015952.SGD","LU0795875169.SGD","LU2362540622.SGD","LU0889566641.SGD","LU1489326972.SGD","LU2357627491.SGD","CLSE","LU1074936037.SGD","LU2750360641.GBP","SOXX","LU1188199696.SGD","LU1236620750.USD","LU1861127337.USD","LU2242649171.HKD","LU0345769631.USD","LU1316542783.SGD","LU0985320562.USD","LU2360032135.SGD","LU2125909759.SGD","LU1989764664.SGD","PLTR","LU0265550359.USD","IE00B19Z8W00.USD","BK4538","LU0316494557.USD","IE0000B7K699.USD","BK4577","LU0234570918.USD","USD","LU1037948541.HKD","LU1935042215.USD","LU0256863811.USD","GPZ","IE000KEQY171.SGD","LU1791710582.SGD","LU1778281490.HKD","LU2458330243.SGD","LU1670710661.SGD","GAMR","LU0081259029.USD","IE00BKDWB100.SGD","BK4613","LU0994945656.USD","LU1035773651.USD","LU0690374615.EUR","LU1366333091.USD","LU0433182093.SGD","LU2087621335.USD","ORCX","LU1066053197.SGD","PLTA","LU0079474960.USD","TTEQ","LU0345774391.USD","BK4123","LU0208291251.USD","LU1852331112.SGD","LU0158827781.USD","LU2092937148.SGD","HK0000304797.USD","LU1043141396.HKD","LU2756315664.SGD","NVIW.SI","IE00BMPRXQ63.HKD","LU1066051225.USD","LU2092627202.USD","ORCL","LU0823434740.USD","LU0871640123.AUD","PLTG","LU2487616109.SGD","IE00BWXC8680.SGD","IE00BFSS7M15.SGD","IE00BMPRXN33.USD","LU1046421795.USD","LU2637965513.SGD","LU1934455194.USD","LU1127390331.HKD","LU2361044865.SGD","LU0957791311.USD","LU2023250504.SGD","SG9999014880.SGD","LU0130102774.USD","USXF","LU1732800096.USD","LU0354030438.USD","LU1201861249.SGD","BK4532","BK4543","BK4549","LU0511384066.AUD","LU2357305700.SGD","LU2417539215.USD","LU1670711040.USD","SGXZ99366536.SGD","BK4533","LU1861215975.USD","LU0310800379.SGD","LU2456880835.USD","HK0000304805.HKD","SGXZ81514606.USD","LU0823421333.USD","LU0149725797.USD","LU2471134952.CNY","AON","IE000WAW04H5.SGD","LU0162691827.USD","LU0823417737.USD","LU2097829019.USD","BK4534","3NVD.UK","IE00B19Z9505.USD","LU0960925559.SGD","LU1280957306.USD","BK4547","SOXQ","PLTW","LU0466842654.USD","LU2491050071.SGD","LU0070302665.USD","LU0898699433.AUD","LU1979441026.SGD","FAI","LU1861559042.SGD","LU1582986433.USD","LU0787776722.HKD","LU2461242641.AUD","LU2108987350.USD","07788","IE0034235303.USD","LU0912757837.SGD","LU1720051108.HKD","VGT","ESUM","LU1564329461.SGD","LU1244550577.SGD","IE00BJJMRX11.SGD","LU0174119429.USD","LU0323239441.USD","NVDY","LU1582987597.SGD","LU1923622291.USD","SPLTRmain","LU1032466523.USD","LU1400636574.HKD","LU2249611893.SGD","LU2322448791.USD","LU1989772840.SGD","IE00B7SZLL34.SGD","IE00B19Z9P08.USD","HK0000306685.HKD","LU0106261372.USD","LU0210536198.USD","LU0251131958.USD","LU1868836591.USD","LU2360108059.USD","FTEC","LU0106831901.USD","LU0170899867.USD","LU0127658192.USD","BK4528","IE0003U64NQ7.SGD","LU1815333072.USD","LU0980610538.SGD","LU1629891620.HKD","LBO","LU0158827948.USD","LU1974910355.USD","LU1145028129.USD","LU1791807156.HKD","LU2125154935.USD","LU0868494617.USD","LU0289960550.SGD","BK4503","LU2063271972.USD","IE00BZ1G4Q59.USD","LU1551013425.SGD","LU0965509101.SGD","LU1983260115.SGD","LU2602419157.SGD","LU2023250843.SGD","IE00BZ199S13.USD","LU1914381329.SGD","IE00BJJMRY28.SGD","LU0820562030.AUD","HK0000320223.HKD","LU1670756490.USD","LU2720916845.USD","SG9999004303.SGD","LU2133065610.SGD","LU2394011477.USD","LU0211331839.USD","IXN","IE00B19Z3581.USD","LU2272731782.SGD","LU0823414551.USD","LU0426417589.USD","MSFC","LU0724617625.USD","NVDO","LU1721428933.USD","LU0868494708.USD","BK4592","LU0965509283.SGD","LU2211815571.USD","ABFL","LU1821325948.USD","LU0289961442.SGD","LU1564329115.USD","LU2592432038.USD","SG9999014898.SGD","LU1366192091.USD","LU1221951129.SGD","SG9999015358.SGD","LU1334329650.SGD","LU0545562505.USD","LU0882574139.USD","LU2087625088.SGD","LU1236620834.HKD","LU0203201768.USD","LU1242518857.USD","LU2237438978.USD","LU2420271590.USD","MSFX","LU1880398554.USD","IE000YTNTUN2.SGD","LU2279689827.SGD","TYLG","LU2237443622.USD","LU0072461881.USD","LU1548497426.USD","LU0949170426.SGD","LU0274383776.USD","LU1571399168.USD","LU1119994496.HKD","LU2413666426.HKD","LU2404859667.USD","IE000BZT7R73.USD","LU1069344957.HKD","IE00BYXW3230.USD","TRFK","LU1868837300.USD","ORCS","IE00BMPRXR70.SGD","ORCU","LU0069063385.USD","LU2095319765.USD","LU2430703178.SGD","NVDQ","SG9999015341.SGD","LU2125154778.USD","2NVD.UK","LU1261432733.SGD","LU1301847155.USD","LU2089985449.USD","LU1917777945.USD","LU1066051498.USD","IE000F7OJYX1.SGD","LU2237957902.USD","OGIG","LU0661504455.SGD","LU2505996681.GBP","LU0198837287.USD","LU0792757196.USD","LU2237443895.HKD","LU2237443382.USD","LU0109392836.USD","IE00BDRTCR15.USD","LU1235295455.SGD","TDIV","AGOX","LU1934455863.HKD","LU0097036916.USD","LU0957808578.USD","LU1670627923.USD","LU0048584097.USD","LU0528227936.USD","LU2083900584.USD","LU2298321311.HKD","DIPS","LU1066051811.HKD","IE00BJTD4V19.USD","IE00BD6J9T35.USD","LU2433249047.HKD","SG9999001077.SGD","LU0784385840.USD","LU0823414478.USD","LU0057025933.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667887","title":"First Marijuana, Then Peptides. Why Psychedelics are Wall Street's Next Big Trip.","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667887","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667887?lang=en_us&edition=fundamental","pubTime":"2026-09-14 23:53","pubTimestamp":1789401180,"startTime":"0","endTime":"0","summary":"First marijuana, then peptides-and now psychedelics are getting a second look, as Definium Therapeutics advances the case for medical LSD.The drugmaker on Monday reported positive late-stage trial dat","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667648676","title":"Definium Therapeutics Inc : Leerink Partners Raises Target Price to $70 from $52","url":"https://stock-news.laohu8.com/highlight/detail?id=2667648676","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667648676?lang=en_us&edition=fundamental","pubTime":"2026-09-14 22:14","pubTimestamp":1789395280,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nFWN4560CC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667658276","title":"Definium Therapeutics Price Target Maintained with a $66.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2667658276","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667658276?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:00","pubTimestamp":1789387200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667736663","title":"Definium Therapeutics Shares Gain After Reporting Positive Results in Anxiety Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2667736663","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667736663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:54","pubTimestamp":1789386840,"startTime":"0","endTime":"0","summary":"Definium Therapeutics said it reported positive topline results from its second phase 3 study of DT120, an orally disintegrating tablet in adults with generalized anxiety disorder.This is its third positive phase 3 readout for DT120 ODT, following positive results in major depressive disorder announced in June and in generalized anxiety disorder announced in August.Shares were halted earlier in premarket trading and have resumed, gaining 18.7% and trading at $38.89 on Monday.The company said the latest study met the primary endpoint along with key secondary efficacy endpoints. This demonstrates a statistically-significant and clinically-meaningful improvement from baseline compared with a placebo, as measured by the change in Hamilton Anxiety Rating Scale total score at Week 12, it said.The drug was generally well-tolerated, with a safety profile consistent with prior clinical experience, the company said.\"Building on this momentum, we are advancing toward an NDA submission and look fo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667813663","title":"Definium Therapeutics Shares Jump 20% Premarket After Co's Lsd-Based Drug Lowers Anxiety in Second Successful Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2667813663","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667813663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:32","pubTimestamp":1789385576,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4N4560TP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667663887","title":"S&P 500 Futures Decline in Premarket Trading; Definium Therapeutics, Primo Brands Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=2667663887","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667663887?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:30","pubTimestamp":1789385400,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Barrons.com using technology from Automated Insights.With U.S. stock markets set to open in two hours, Definium Therapeutics Inc. (DFTX) was up 15.7% in pre","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLI","LGDX","UOCT","VSL","FELC","VOO","VUG","HJUN","LGH","VOOG","DSPY","TOPC","XPAY","XSPI","HELO","XUSP","FLAO","ISSXF","PTLC","GSUS","VYM","SCHG","CGUS","DBB","XXX",".SPX","UXAP","FEBT","PBJL","TSPA","ABIG","ACLC","FLCC","CPST","MRCP","SSS","VOOX","SPY","CFO","PRMB","SPYM","SPDF","OALC","GBXB","DFTX","PTL","UXJA","UXJL","GPIX","BKLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667765049","title":"Definium Therapeutics: DT120 Odt 100 Mcg Generally Well Tolerated with Consistent Safety Profile; no New Safety Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=2667765049","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667765049?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:00","pubTimestamp":1789383600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nP8N40P08T:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667650490","title":"Definium Therapeutics: DT120 Pre-Nda Meeting Scheduled for Q4; Nda Filing Expected H1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2667650490","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667650490?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:00","pubTimestamp":1789383600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nP8N40P08T:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667650415","title":"Definium Therapeutics: Phase 3 Panorama Study of DT120 Odt Met Primary & Key Secondary Endpoints in Generalized Anxiety Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2667650415","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667650415?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:00","pubTimestamp":1789383600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nP8N40P08T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667507966","title":"Definium's LSD-Based Drug Lowers Anxiety in Second Successful Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2667507966","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667507966?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:00","pubTimestamp":1789383600,"startTime":"0","endTime":"0","summary":"Definium's LSD-based drug lowers anxiety in second successful late-stage studySept 14-Definium TherapeuticsDFTX.Osaid on Monday its LSD-based treatment reduced symptoms of generalized anxiety disorder","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL6N4560MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667418650","title":"Definium Therapeutics: DT120 Odt 100 Mcg Showed Placebo-Adjusted Hamilton Anxiety Rating Scale Reduction of 5.1 Points at Week 12","url":"https://stock-news.laohu8.com/highlight/detail?id=2667418650","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667418650?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:00","pubTimestamp":1789383600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nP8N40P08T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667148650","title":"NASDAQ Trade Halt Halt News Pending at 06:55 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2667148650","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667148650?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:55","pubTimestamp":1789383300,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTHALT NEWS PENDING AT 06:55 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nAQN2MJ4TH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667657172","title":"U.S. Research Roundup-ACV Auctions, Crown Castle, Lennox International","url":"https://stock-news.laohu8.com/highlight/detail?id=2667657172","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667657172?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:22","pubTimestamp":1789381349,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-ACV Auctions, Crown Castle, Lennox InternationalSept 14 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, includ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4N4560NX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BEX","ADBG","GXPE","CPK","MPC","DFTX","CCI","BE","FIG","MARA","JKHY","DINO","EBAY","FRSH","DBI","FCNCA","CAPR","ADBE","MARO","ALGT","OWNB","LII","KRSA","ERII","LRMR","KR","GSIT","EGP","CEVA","ECHO","CPT","FLNC","CALY","DRI","AZO","CRWV","GM","ADUS","DTCR","LYNX","EIX","EXP","DVN","DK","ACVA","XTN","MAAY","SMOG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667652775","title":"Definium Therapeutics Issues Inducement Stock Options for 56,650 Shares to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2667652775","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667652775?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:00","pubTimestamp":1789380036,"startTime":"0","endTime":"0","summary":"Definium Therapeutics issues inducement stock options for 56,650 shares to new hiresDefinium Therapeutics issued inducement stock options covering 56,650 common shares to three newly hired non-executi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL36dVPz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667335576","title":"Definium Therapeutics to Present Phase 3 Panorama Topline Data for DT120 in Generalized Anxiety Disorder Sept. 14","url":"https://stock-news.laohu8.com/highlight/detail?id=2667335576","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667335576?lang=en_us&edition=fundamental","pubTime":"2026-09-14 05:00","pubTimestamp":1789333219,"startTime":"0","endTime":"0","summary":"Definium Therapeutics to present Phase 3 Panorama topline data for DT120 in generalized anxiety disorder Sept. 14Definium Therapeutics scheduled a Sept. 14, 2026 webcast to discuss topline results fro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260913:nNDL5r74pJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667633552","title":"Definium Therapeutics to Discuss Topline Results from Phase 3 Panorama Study in Generalized Anxiety Disorder on September 14, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2667633552","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667633552?lang=en_us&edition=fundamental","pubTime":"2026-09-14 05:00","pubTimestamp":1789333201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260913:nTUA4KL4QW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666257316","title":"Definium Therapeutics' Upcoming Phase 3 Data on DT120 to De-Risk Program, Back FDA Approval, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2666257316","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666257316?lang=en_us&edition=fundamental","pubTime":"2026-09-11 23:33","pubTimestamp":1789140826,"startTime":"0","endTime":"0","summary":"Definium Therapeutics'  upcoming phase 3 data on DT120 in generalized anxiety disorder or GAD is likely to further de-risk the program and back potential approval, RBC Capital Markets said in a Friday note.The first phase 3 trial in GAD met its primary endpoint and a positive data readout from the second phase 3 trial should ease residual regulatory uncertainty on the therapy's approvability, the brokerage said. Data from the second phase 3 trial is due for release \"any day now,\" RBC noted.Trial results are likely to support approval from the US Food and Drug Administration given DT120's robust efficacy data, well-powered studies, and the FDA's flexibility for neuropsychiatric drugs, according to the investment firm.RBC has an outperform rating on Definium Therapeutics, with a $66 price target.Price: 38.53, Change: +0.80, Percent Change: +2.12","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4588","DFTX","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}